Vybion, Inc.

By Vybion, Inc. | January 30, 2017

Vybion Huntington’s Disease Drug Patent Receives Track I Status

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.